Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease
Clinical trial NCT00082602 · COMPLETED
Trial details
- NCT number
- NCT00082602
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.